AMRA Medical's technology allows professionals to access multiple body composition biomarkers and disease insights through a rapid MRI.
A company in a late-growth stage that has already received funds. It shows a high level of transparency and communicates its mission and vision, including a commitment to the SDGs, and reports on sustainability and impact. The startup's beneficiaries usually range from small communities to a continental scale, and it has a positive impact on the planet and people. The risk that impact will not occur as expected is medium.
The precision of AMRA Medical's technology allows for the measure of volumetric changes and diffuse fat infiltration into muscle.
Automatically produced multiple fat and muscle biomarkers with unrivaled precision and accuracy, alongside contextual disease insights, all from a single, rapid whole-body MRI.
To confront global health challenges by establishing the foundation for body composition measurement and providing the knowledge to predict and prevent diseases.
Data insights and access to rapid MRI technology